Aggressivity, suicide attempts, and depression: Relationship to cerebrospinal fluid monoamine metabolite levels

Biological Psychiatry

Volumn 50, Issue 10, 2001, Pages 783-791

  Placidi, Giovanni P A ^a,b   Oquendo, Maria A ^a,b   Malone, Kevin M ^a,b   Huang, Yung Yu ^a,b   Ellis, Steven P ^a,b   Mann, J John ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Aggressivity; Cerebrospinal fluid; Depression; Monoamine metabolites; Serotonin; Suicide intent

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID; MONOAMINE;

ADULT; AGGRESSION; AGGRESSIVENESS; ARTICLE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; EVALUATION; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLITE; NORADRENERGIC SYSTEM; PATIENT SELECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUICIDE ATTEMPT;

ADULT; AGGRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; SUICIDE, ATTEMPTED;

EID: 0035890923     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01170-2     Document Type: Article

References (48)

1. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid. II. Suicide
2. Depressive symptom patterns and urinary MHPG excretion
3. CSF monoamine metabolites in melancholia
4. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?
5. Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests
6. Classification of suicidal behaviors: I. Quantifying intent and medical lethality
7. Assessment of suicidal intention: The scale for suicide ideation
8. Components of suicidal intent in completed and attempted suicides
9. An inventory for measuring depression
10. Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts
11. Aggression, suicide and serotonin: Relationships to CSF amine metabolites
12. Cerebrospinal fluid correlates of suicide attempts and aggression
13. Aggression in human correlates with cerebrospinal fluid amine metabolites
14. Human aggression and suicide: Their relationship to neuropsychiatric diagnoses and serotonin metabolism
15. 2A receptor binding
16. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia
17. CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects
18. Skin conductance habituation and cerebrospinal fluid 5-hydroxyindoleacetic acid in suicidal patients
19. CSF metabolites in borderline personality disorder compared with normal controls
20. Uncoupling of serotonergic and noradrenergic systems in depression: Prelinimary evidence from continuous cerebrospinal fluid sampling
21. A rating scale for depression
22. A replication study of violent and nonviolent subjects: Cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids
23. CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide
24. CSF and urinary biogenic amines and metabolism in depression and mania. A controlled univariate analysis
25. 5-hydroxyindoleacetic acid levels in attempted suicides who have killed their children
26. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior
27. Cerebrospinal fluid amines and higher lethality suicide attempts in depressed inpatients
28. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients
29. Towards a clinical model of suicidal behavior in psychiatric patients
30. Suicide and antidepressants
31. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients
32. CSF 5-HIAA predicts suicide risk after attempted suicide
33. CSF amine metabolites in depression
34. CSF 5HIAA and personal and family history of suicide in affectively ill patients: A negative study
35. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: Relationship to suicidal behavior and dexamethasone nonsuppression
36. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study
37. Depression among alcoholics: Relationship to clinical and cerebrospinal fluid variables
38. Simultaneous determination of 3-methoxy-4-hydroxphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection
39. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal
40. Depressive mania versus agitated depression: Biogenic amine and hypothalamic-pituitary-adrenocortical function
41. Prediction of suicidal behavior from biologic tests
42. Monoamine metabolites in CSF and suicidal behavior
43. Central monoamine metabolism in depressions. II. Catecholamines and related compounds
44. A prospective follow-up study of alcoholic violent offenders and fire setters
45. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers
46. Depression and anxiety: Role of the locus coeruleus and corticotropin-releasing factor
47. CSF monoamine metabolites in patients and controls: Support for a bimodal distribution in major affective disorders